Trials / Completed
CompletedNCT04616742
Study to Evaluate the Mass Babance and Biotransformation of [14C]SHR6390 in Healthy Adult Male Volunteers
A Phase I Mass Balance and Biotransformation Study of [14C]SHR6390 in Chinese Healthy Adult Male Volunteers.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Study to Evaluate the mass balance and biotransformation of single dose \[14C\]SHR6390 in Chinese healthy adult male volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | [14C]SHR6390 | Patients will receive single dose of orally \[14C\]SHR6390 on Day 1. |
Timeline
- Start date
- 2020-11-11
- Primary completion
- 2021-01-08
- Completion
- 2021-05-01
- First posted
- 2020-11-05
- Last updated
- 2021-05-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04616742. Inclusion in this directory is not an endorsement.